Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: Report
Serum Institute's Chairman Cyrus Poonawalla Bats For Booster Dose Of Covishield After Six Months
Govt Places Order For 66 Crore COVID-19 Vaccine Doses From Serum Institute, Bharat Biotech
Serum Institute Likely To Begin Clinical Trial Of Covovax On Children In India From Next Month: Report
Amid Looming Uncertainty Over EUA In US, Novavax Eyes India Launch Of Its COVID Jab With Over 90 Per Cent Efficacy
Govt's Expert Panel Mulls Increasing Gap Between Covishield's Two Doses To Boost Efficacy, Vaccination Drive
Covishield May Offer Protection Against Double Mutant Strain: CCMB Report
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra
Lift Embargo On Vaccine Raw Material Exports: Serum Institute's Adar Poonawalla Urges US President Biden
The Covid-19 ‘Vaccine Shortage’: What Is Really Happening?
WHO Approves Two Versions Of Oxford-AstraZeneca Covid-19 Vaccine Including SII's Covishield For Emergency Use
Health Ministry Says It Doesn't Agree With Calculation Of Rs 80,000 Crore For Covid-19 Vaccine Distribution
After Oxford Covid-19 Vaccine, Serum Institute Likely To Start Clinical Trials Of Novavax's Vaccine Candidate In India
Serum Institute To Begin Human Clinical Trials Of Oxford University's Covid-19 Vaccine In India From Today
